thiophenes has been researched along with Age-Related Macular Degeneration in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Glassman, AR | 1 |
| Byeon, SH; Kim, SS; Koh, HJ; Lee, CS; Lee, JH; Lee, SC | 1 |
| Fineman, MS; Garg, SJ; Hsu, J; Shahlaee, A; Spirn, MJ; Sridhar, J; Vander, J | 1 |
| Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B | 1 |
| Ciulla, TA; Garzozi, HJ; Harris, A; Kagemann, L; Piper, HC; Pratt, LM; Rechtman, E | 1 |
| Arend, O; Remky, A; Sponsel, WE; Weber, A | 1 |
| Biswas, S; Parry, NR; Sikkink, SK; Stanga, PE; Trump, D | 1 |
| Hussar, DA | 1 |
1 review(s) available for thiophenes and Age-Related Macular Degeneration
| Article | Year |
|---|---|
X-linked retinoschisis: an update.
Topics: Adult; Age of Onset; Animals; Biopolymers; Cell Adhesion; Child; Child, Preschool; Chromosomes, Human, X; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Disease Models, Animal; Disease Progression; Eye Proteins; Female; Genes, X-Linked; Genetic Carrier Screening; Genetic Counseling; Genetic Therapy; Humans; Infant; Macular Degeneration; Male; Mice; Phenotype; Prevalence; Protein Structure, Tertiary; Retinoschisis; Sulfonamides; Thiophenes | 2007 |
3 trial(s) available for thiophenes and Age-Related Macular Degeneration
| Article | Year |
|---|---|
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimonidine Tartrate; Chemoprevention; Clonidine; Drug Combinations; Female; Humans; Hypotonic Solutions; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2012 |
The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration.
Topics: Aged; Antihypertensive Agents; Choroid; Coloring Agents; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Retinal Vessels; Sulfonamides; Thiophenes | 2003 |
Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Humans; Macular Degeneration; Male; Pilot Projects; Prospective Studies; Sulfonamides; Thiophenes; Visual Acuity; Visual Field Tests; Visual Fields | 2005 |
4 other study(ies) available for thiophenes and Age-Related Macular Degeneration
| Article | Year |
|---|---|
Are P Values Enough?
Topics: Humans; Macular Degeneration; Sulfonamides; Thiophenes; Timolol | 2020 |
EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Bevacizumab; Drug Combinations; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macula Lutea; Macular Degeneration; Male; Ophthalmic Solutions; Ranibizumab; Retrospective Studies; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2019 |
Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration.
Topics: Administration, Topical; Aged; Aged, 80 and over; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intravitreal Injections; Macular Degeneration; Male; Prospective Studies; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Risk Assessment; Severity of Illness Index; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Vascular Endothelial Growth Factor A | 2016 |
New drug update: 2007.
Topics: Aged; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antiparkinson Agents; Antipsychotic Agents; Drug Approval; Fumarates; Humans; Hypoglycemic Agents; Isoxazoles; Macular Degeneration; Paliperidone Palmitate; Pyrazines; Pyrimidines; Ranibizumab; Sitagliptin Phosphate; Tetrahydronaphthalenes; Thiophenes; Triazoles; United States | 2008 |